Notch‑1 inhibition reduces proliferation and promotes osteogenic differentiation of bone marrow mesenchymal stem cells

  • Authors:
    • Ying He
    • Lijin Zou
  • View Affiliations

  • Published online on: July 10, 2019     https://doi.org/10.3892/etm.2019.7765
  • Pages: 1884-1890
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Low differentiation and high proliferation rates are critical factors affecting bone marrow mesenchymal stem cell (BMSC) tumorigenesis. The present study aimed to investigate the role of the Notch signaling pathway in BMSC proliferation and osteogenic differentiation. Mouse BMSCs were divided into control, vector, Notch1‑small interfering (si)RNA, γ‑secretase inhibitor, and Notch1‑siRNA + γ‑secretase inhibitor groups. The siRNA‑Notch1, γ‑secretase inhibitor, and Notch1‑siRNA + γ‑secretase inhibitor groups were treated with Notch1 siRNA and/or γ‑secretase inhibitor. Following treatment, cell proliferation was evaluated using a Cell Counting Kit‑8. Tumor‑related factors, including transforming growth factor (TGF)‑β1, c‑Myc and p53, were detected by reverse transcription‑quantitative polymerase chain reaction and western blot analyses. BMSC osteogenic differentiation was induced and the cells were stained with alizarin red at 14 and 21 days. Alkaline phosphatase (AKP) activity was also evaluated. The siRNA‑Notch1 and γ‑secretase inhibitor both reduced BMSC proliferation and the expression of TGF‑β1 and c‑Myc and increased the expression of p53. Following the induction of osteogenesis and staining with alizarin red, the level of AKP was significantly higher in cells in the siRNA‑Notch1 and γ‑secretase inhibitor groups compared with that in the control group. It was found that Notch1 inhibition reduced proliferation and promoted the osteogenic differentiation of BMSCs.
View Figures
View References

Related Articles

Journal Cover

September-2019
Volume 18 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
He Y and He Y: Notch‑1 inhibition reduces proliferation and promotes osteogenic differentiation of bone marrow mesenchymal stem cells. Exp Ther Med 18: 1884-1890, 2019
APA
He, Y., & He, Y. (2019). Notch‑1 inhibition reduces proliferation and promotes osteogenic differentiation of bone marrow mesenchymal stem cells. Experimental and Therapeutic Medicine, 18, 1884-1890. https://doi.org/10.3892/etm.2019.7765
MLA
He, Y., Zou, L."Notch‑1 inhibition reduces proliferation and promotes osteogenic differentiation of bone marrow mesenchymal stem cells". Experimental and Therapeutic Medicine 18.3 (2019): 1884-1890.
Chicago
He, Y., Zou, L."Notch‑1 inhibition reduces proliferation and promotes osteogenic differentiation of bone marrow mesenchymal stem cells". Experimental and Therapeutic Medicine 18, no. 3 (2019): 1884-1890. https://doi.org/10.3892/etm.2019.7765